Skip to content

Study of Alambushadyam churna (powder) in the management of Anemia.

Randomized controlled clinical trial to study the efficacy of Alambushadyam churna in the management of Pandu. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/111021
Enrollment
66
Registered
2026-05-25
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D649- Anemia, unspecified

Interventions

None listed

Sponsors

Vd Shivani Kousalye PG Scholar at Bhartiya sanskriti Darshan Trusts Ayurved Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having lakshana like panduta ,agnimandya, daurbalya, bhrama , jwar shwas, gaurav, akshikutshotha, nidralu, arohanasyaayasvishesh shwas will be selected. 2. Patients having any 3-4 above mentioned lakshana will be enrolled in the study. 3. Patients of any gender will be selected between age group 20 to 60 yrs. 4. Hemoglobin percentage more than 7 gm/dl and less than 12 gm/dl .

Exclusion criteria

Exclusion criteria: 1. Known case of aplastic anemia, sickle cell anemia. 2. Pregnant women, lactating mothers. 3. Patients with hemorrhagic disorders. 4. Patient with severe systemic disorders and surgical illness.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Alambushadyam churna in the management of Pandu with respect to symptom & complete blood count.Timepoint: Assessment on 0th day ,15 th day 30 th day .

Secondary

MeasureTime frame
To compare the effect of the Alambushadyam churna and Talisadi churna in the management of Pandu. To observe the adverse effect of Alambushadyam churna if any.Timepoint: Assessment on 0th day ,15 th day 30 th day .

Countries

India

Contacts

Public ContactVd Anjali Aniruddha Deshpande

Bhartiya Sanskriti Darshan Trusts Ayurved Mahavidyalaya

anjalidesh1610@gmail.com9730069747

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026